Clearstead Advisors’s Bio-Techne TECH Stock Holding History

Clearstead Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Buy	31 +4	+15%	+$216	﹤0.01%	2453
2026 Q1	$1.41K	Buy	27 +15	+125%	+$900	﹤0.01%	1973
2025 Q4	$706	Sell	12 -350	-97%	-$21.3K	﹤0.01%	2270
2025 Q3	$20.1K	Sell	362 -411	-53%	-$22K	﹤0.01%	1642
2025 Q2	$39.8K	Sell	773 -399	-34%	-$20K	﹤0.01%	1357
2025 Q1	$68.7K	Sell	1,172 -277	-19%	-$18.8K	﹤0.01%	1088
2024 Q4	$104K	Sell	1,449 -461	-24%	-$33.9K	﹤0.01%	1017
2024 Q3	$153K	Buy	1,910 +57	+3%	+$4.28K	﹤0.01%	928
2024 Q2	$133K	Buy	+1,853	New	+$136K	﹤0.01%	936
2022 Q2	–	Sell	-116	Closed	-$13K	–	1444
2022 Q1	$13K	Buy	+116	New	+$12K	﹤0.01%	955

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Clearstead Advisors's TECH Position: Q2 2026 in Review

Clearstead Advisors increased its Bio-Techne (TECH) stake by 15% in Q2 2026, buying an estimated $216 and bringing the position to 31 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

Clearstead Advisors first reported a position in TECH in Q1 2022 and has held it in 10 quarters since. The position peaked at $153K in Q3 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Clearstead Advisors held 31 shares of Bio-Techne worth $2.19K as of Q2 2026.
Clearstead Advisors bought 4 Bio-Techne shares in Q2 2026, an estimated $216.
Bio-Techne made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2453 holding.
Clearstead Advisors first reported a position in Bio-Techne in Q1 2022 and has held it in 10 quarters since.
Clearstead Advisors's Bio-Techne position peaked at $153K in Q3 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.